Targeting RAS signalling pathways in cancer therapy.

Area of Science:

• Oncology
• Molecular Biology
• Cancer Signalling

Background:

• RAS proteins are crucial regulators of cell signaling pathways.
• Aberrant RAS signaling is implicated in the development and progression of most human cancers.
• Mutations in RAS genes or alterations in associated signaling components lead to uncontrolled cell growth.

Purpose of the Study:

• To review the role of RAS proteins in cell growth and malignant transformation.
• To discuss the therapeutic potential of targeting RAS signaling pathways in cancer treatment.
• To highlight emerging therapeutic agents targeting the RAS pathway.

Main Methods:

• Literature review of studies on RAS protein function and cancer.
• Analysis of current therapeutic strategies targeting RAS pathways.
• Overview of clinical trial data for novel RAS-targeted agents.

Main Results:

• RAS pathway dysregulation is a common driver in human malignancies.
• Targeting RAS signaling demonstrates potential for inhibiting tumor growth, survival, and metastasis.
• Several novel therapeutic agents targeting RAS pathways are progressing through clinical development.

Conclusions:

• The RAS signaling network is a critical target for cancer therapy.
• Targeted therapies offer a rational approach to combatting RAS-driven cancers.
• Ongoing research and development hold promise for improved patient outcomes in various cancers.